Dongfeng Qu
4PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 27, 2024
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases.Landon L Moore, Dongfeng Qu, Sripathi Sureban
|Nov 11, 2022
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.Ling Ding, Yuning Yang, Qin Lu
|Dec 22, 2020
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan
|Aug 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer.Dongfeng Qu, Nathaniel Weygant, Jiannan Yao
Pageof 1
Frequent Collaborators
2 joint publications
Courtney W Houchen
2 joint publications
Nathaniel Weygant
1 joint publications
Jiannan Yao
1 joint publications
Randal May
1 joint publications
Guangyu An
1 joint publications
Parthasarathy Chandrakesan
1 joint publications
Landon L Moore
1 joint publications
Kamille Pitts
1 joint publications
Nasya Cooper
1 joint publications
Kai Ding
